Skip to main content

Day: March 29, 2022

Exela Technologies Closes Revolving Loan Exchange and Prepayment; Removes Last Remaining Senior Debt Maturity in 2022

– Further progress made against previously announced balance sheet strengthening and strategic initiatives IRVING, Texas, March 29, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), announced today that certain of its subsidiaries closed a Revolving Loan Exchange and Prepayment Agreement with the financial institutions acting as revolving lenders under its First Lien Credit Agreement dated as of July 12, 2017. All of the amounts outstanding under the revolving facility were prepaid with $50 million of cash and the remainder exchanged for $50 million of 11.500% First-Priority Senior Secured Notes due 2026. As a result, there are no further senior debt maturities in 2022. The closing of the revolver is one of the last steps in the initiative to strengthen the balance sheet announced...

Continue reading

ECGI Approaching Key Strategic Milestones in the Cannabinoid Marketplace

The Company is working toward multiple deals to drive shareholder value by adding IP, talent and operating assets LOS ANGELES, March 29, 2022 (GLOBE NEWSWIRE) — via InvestorWire – ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, is pleased to offer current and prospective shareholders with the following update on the Company’s operations. “We are working to finalize a transaction to acquire key assets that will serve the purpose of granting us our Major Use License for the upcoming year so we can start our cultivation operations in full,” said William Chung, CEO of ECGI Holdings. Beyond that strategic move, management notes that the Company is working toward several key acquisitions...

Continue reading

PSYC Secures $350K in Private Equity-Based Capital Financing

LAKE OSWEGO, OR, March 29, 2022 (GLOBE NEWSWIRE) — PSYC Corporation (OTCPink: PSYC) (“PSYC” or the “Company”) a media leader for the emerging sector of medicinal psychedelics and authorities behind Psychedelic Spotlight, a top ranking psychedelic news and information platform, is pleased to announce the Company successfully secured $350,000 in equity-based financing. Pursuant to the terms of the investment, a total of 17,500,000 shares of PSYC common stock were sold at a price of $0.02 per share and include warrant options for the right to purchase up to an additional 20M shares over the next 12 months. The investment was completed by Trent Sullivan of Jackson, Tennessee and is a private, accredited investor.  “We are incredibly grateful to Mr. Sullivan for the resounding faith he is demonstrating in the future of PSYC by way of...

Continue reading

Resolutions of Ordinary General Meeting of AB “Ignitis grupė“ shareholders

The Extraordinary General Meeting of shareholders of AB “Ignitis grupė” (hereinafter – the Group, legal entity code 301844044, registered office at Laisvės ave. 10, Vilnius, held on 29 March, 2022, adopted the following resolutions: 1.       Regarding the assent to AB “Ignitis grupė” consolidated annual report for the year 2021, except for the part of the remuneration report.1.1. To assent to AB „Ignitis grupė“ consolidated annual report for the year 2021, except for the part of the remuneration report (link). 2.       Regarding the assent to the remuneration report of AB “Ignitis grupė”, as a part of the consolidated annual report of AB “Ignitis grupė” for the year 2021.        2.1. To assent to the remuneration report of AB “Ignitis grupė”, as a part of the consolidated annual report of AB “Ignitis grupė” for the year 2021 (link). 3.      ...

Continue reading

Resolutions of Ordinary General Meeting of AB “Ignitis grupė“ shareholders

The Extraordinary General Meeting of shareholders of AB “Ignitis grupė” (hereinafter – the Group), legal entity code 301844044, registered office at Laisvės ave. 10, Vilnius, held on 29 March, 2022, adopted the following resolutions: 1.       Regarding the assent to AB “Ignitis grupė” consolidated annual report for the year 2021, except for the part of the remuneration report.1.1. To assent to AB „Ignitis grupė“ consolidated annual report for the year 2021, except for the part of the remuneration report (link). 2.       Regarding the assent to the remuneration report of AB “Ignitis grupė”, as a part of the consolidated annual report of AB “Ignitis grupė” for the year 2021.        2.1. To assent to the remuneration report of AB “Ignitis grupė”, as a part of the consolidated annual report of AB “Ignitis grupė” for the year 2021 (link). 3.      ...

Continue reading

PyroGenesis Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call

MONTREAL, March 29, 2022 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG), today announced that it plans to host a conference call at 10:00 AM Eastern Time on Friday, April 1, 2022 to discuss the Company’s financial results for the 2021 fiscal year ended December 31, 2021, as well as the Company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 877-800-3460 for U.S. callers or for international callers +1 615-622-8042 and by entering access code: 2253876. A webcast of the...

Continue reading

MultiChoice Accelerator Programme Celebrated at World Expo 2020, Dubai

MultiChoice Accelerator MultiChoice Accelerator Programme Celebrated at World Expo 2020, DubaiJohannesburg, March 29, 2022 (GLOBE NEWSWIRE) — Team South Africa celebrated their overall success by hosting the last National Day at the World Expo 2020 Dubai.  Expo 2020, which started in October 2021, saw almost 200 countries come together to display their offerings, while scouting networking opportunities, drawing investments, and solidifying relationships and future partnerships. The Department of Trade, Industry and Competition (dtic), together with MultiChoice as the official broadcast partner, set out to introduce the diverse economic value that South Africa has to offer. The six-month participation was closed out with a national ceremony hosted by the Honourable President Cyril Ramaphosa, followed by a high-level panel discussion...

Continue reading

Water Ways Receives a C$730,000 Third Blueberries Irrigation System Order in China

Third Chinese Blueberries Project Third Chinese Blueberries ProjectNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 29, 2022 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) (“Water Ways” or the “Company“), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, announces that the Company’s Chinese subsidiary (in which the Company hold 73% interest), IRRI-AL TAL (Shanghai) Agriculture Technology Company Ltd. (“IAT Shanghai“), has received an order to install a 250,900 Square Meters (2,700,000 Square Feet) turnkey blueberries irrigation project in the People’s Republic of China. IAT Shanghai is expected to deliver and install the project during Q3...

Continue reading

Innovative MedTech To Enter Digital Payments Market

Innovative MedTech to Expand its Services BLUE ISLAND, Ill., March 29, 2022 (GLOBE NEWSWIRE) — Innovative MedTech, Inc. (the “Company”) (OTC: IMTH), a provider of health and wellness services, today announced that it is expanding its services and planning to enter the digital payments marketplace. As healthcare undergoes its greatest transformation of the modern era, it’s clear that the monolithic system in place is crying for innovation. The Company is answering the call by developing an all-in-one Super Healthcare App that caters to consumers, patients, hospitals, Seniors, and governments, with a solid platform of benefits and online banking. A Digital Healthcare Platform According to the CDC, the U.S. spent $3.6 trillion — 18 percent of its gross domestic product (GDP) — on healthcare, and consumers’ healthcare costs...

Continue reading

Pharvaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

Phase 1 pharmacokinetics study demonstrates PHVS719 well tolerated with extended-release profile supporting once-daily dosingOrphan Drug Designation for PHA121 granted by FDARAPIDe-1, Phase 2 on-demand study of PHVS416 for the treatment of HAE attacks ongoing; top-line data anticipated in 4Q22CHAPTER-1, Phase 2 prophylactic study of PHVS416 for the prevention of HAE attacks trial enrolling patients; top-line data anticipated in 4Q22Executing from a strong financial position with cash and cash equivalents balance of €209.4 million as of December 31, 2021; runway expected into 1Q24ZUG, Switzerland, March 29, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent HAE attacks, building on its deep-seated roots in hereditary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.